Page last updated: 2024-08-22

stanozolol and Pityriasis Rubra Pilaris

stanozolol has been researched along with Pityriasis Rubra Pilaris in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19903 (75.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Agostoni, A; Altomare, GF; Bergamaschini, L; Colombo, A; Finzi, AG; Pigatto, PD; Tucci, A1
Bajaj, P; Jain, S; Sehgal, VN1
Barfield, L; Hashimoto, K; Heller, GL; Iacobelli, D; Pavlidakey, GP; Savoy, LB1
Brice, SL; Spencer, SK1

Other Studies

4 other study(ies) available for stanozolol and Pityriasis Rubra Pilaris

ArticleYear
Effect of stanozolol in patients with pityriasis rubra pilaris and retinol-binding protein deficiency.
    The New England journal of medicine, 1982, Mar-04, Volume: 306, Issue:9

    Topics: Adolescent; Adult; Female; Humans; Male; Middle Aged; Pityriasis Rubra Pilaris; Retinol-Binding Proteins; Stanozolol

1982
Pityriasis rubra pilaris (PRP): report of four cases.
    The Journal of dermatology, 2000, Volume: 27, Issue:3

    Topics: Adult; Aged; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pityriasis Rubra Pilaris; Skin; Stanozolol; Vitamin A; Vitamin E

2000
Stanozolol in the treatment of pityriasis rubra pilaris.
    Archives of dermatology, 1985, Volume: 121, Issue:4

    Topics: Adult; Humans; Male; Pityriasis Rubra Pilaris; Skin; Stanozolol

1985
Stanozolol in the treatment of pityriasis rubra pilaris.
    Archives of dermatology, 1985, Volume: 121, Issue:9

    Topics: Administration, Oral; Humans; Pityriasis Rubra Pilaris; Retinol-Binding Proteins; Stanozolol

1985